Laboratory for General Clinical Chemistry, Academic Medical Centre, University of Amsterdam, the Netherlands.
Thromb Res. 2013 Apr;131(4):357-62. doi: 10.1016/j.thromres.2013.02.004. Epub 2013 Mar 6.
The Coasys® Plus C (Behnk Elektronik, distributed by Roche Diagnostics) is a coagulation analyzer for small to midsize clinical chemistry laboratories. We performed a laboratory evaluation.
After a familiarization period the dead volume, carry-over, capacity, within-assay reproducibility and imprecision were determined for the tests aPTT (STA APTT en STA Cephascreen), PT (STA Neoplastin Plus, STA Neoplastin R), INR (Hepato Quick), fibrinogen (STA Fibrinogen), antithrombin (Antithrombin III) and D-Dimer (Tina-quant D-Dimer Gen.2). A precision test and patient comparison with a STA-R Evolution® system were performed for aPTT (STA Cephascreen), PT (STA Neoplastin R), fibrinogen, antithrombin and D-Dimer.
No carry-over was detected. The analyzer performed on average 66 measurements per hour. Within-assay reproducibility (% with normal/abnormal/extreme result): STA APTT 2.4/1.7/2.7; aPTT Cephascreen 1.4/3.1/1.8; PT Neoplastin Plus 1.2/2.1/1.7; PT Neoplastin R 2.3/-/3.1; INR Hepato Quick 0.6/0.9/1.9; fibrinogen 4.8/3.0/4.5; antithrombin 1.3/4.1/3.8; D-Dimer 19.9/4.3/4.3. Total imprecision (% with control 1/control 2/human pooled plasma): STA APTT 3.1/1.4/2.1; APTT Cephascreen 2.3/2.6/2.0; PT Neoplastin Plus 3.3/1.3/4.1; PT Neoplastin R 3.7/4.0/3.5; INR Hepato Quick 1.5/4.3/1.4; fibrinogen 3.4/5.8/8.1; antithrombin 3.0/6.4/2.4; D-Dimer 4.6/2.2/30.3. The correlation between the Coasys® Plus C and the STA-R Evolution® was good for aPTT, PT, antithrombin and fibrinogen. Some differences were observed for extreme deviant results for fibrinogen. For the analysis of D-Dimer, no sufficient correlation was found between the two analyzers.
The Coasys® Plus C analyzer is fast, easy to handle and safe for the personnel. Its analytical performance makes it suitable for use in a clinical chemistry laboratory.
Coasys® Plus C(Behnk Elektronik,由罗氏诊断公司分销)是一款适用于中小型临床化学实验室的凝血分析仪。我们对其进行了实验室评估。
在熟悉仪器的阶段结束后,我们对 aPTT(STA APTT 和 STA Cephascreen)、PT(STA Neoplastin Plus、STA Neoplastin R)、INR(Hepato Quick)、纤维蛋白原(STA Fibrinogen)、抗凝血酶(Antithrombin III)和 D-二聚体(Tina-quant D-Dimer Gen.2)的死体积、携带污染、容量、批内精密度和不精密度进行了测定。我们还对 aPTT(STA Cephascreen)、PT(STA Neoplastin R)、纤维蛋白原、抗凝血酶和 D-二聚体进行了精密度测试和与 STA-R Evolution®系统的患者比较。
未检测到携带污染。分析仪平均每小时可进行 66 次测量。批内精密度(正常/异常/极端结果的%):STA APTT 2.4/1.7/2.7;aPTT Cephascreen 1.4/3.1/1.8;PT Neoplastin Plus 1.2/2.1/1.7;PT Neoplastin R 2.3/-/3.1;INR Hepato Quick 0.6/0.9/1.9;纤维蛋白原 4.8/3.0/4.5;抗凝血酶 1.3/4.1/3.8;D-二聚体 19.9/4.3/4.3。总不精密度(对照品 1/对照品 2/人混合血浆的%):STA APTT 3.1/1.4/2.1;aPTT Cephascreen 2.3/2.6/2.0;PT Neoplastin Plus 3.3/1.3/4.1;PT Neoplastin R 3.7/4.0/3.5;INR Hepato Quick 1.5/4.3/1.4;纤维蛋白原 3.4/5.8/8.1;抗凝血酶 3.0/6.4/2.4;D-二聚体 4.6/2.2/30.3。Coasys® Plus C 分析仪与 STA-R Evolution®的相关性良好,适用于 aPTT、PT、抗凝血酶和纤维蛋白原的分析。在纤维蛋白原的极端异常结果方面,存在一些差异。对于 D-二聚体的分析,两个分析仪之间没有足够的相关性。
Coasys® Plus C 分析仪快速、易于操作且对人员安全。其分析性能使其适用于临床化学实验室。